Joshua Sabari, MD
@JSabari
Followers
2K
Following
2K
Media
28
Statuses
194
Thoracic medical oncologist, Perlmutter Cancer Center NYU Langone Health. Tweets are my own and not medical advice
New York, NY
Joined November 2010
Honored to be an Expert Judge Mentor for #EGFRSummit! Submit your abstracts by 8/8 to be part of the next class of @EGFRSummit Young Investigators! ➡️ #EGFR #LCSM #MedTwitter #MedEd.
0
2
6
RT @lungoncdoc: Discussing data hot off the press here at #HawaiiLung25. Dr. Joshua Sabari reviews the latest FDA approval of DatoDXd for….
0
2
0
RT @cure_today: Advancements Reshape Treatment for Non-Small Cell Lung Cancer @JSabari @Perlmutter_CC @jainprantesh @RoswellPark #LungCance….
0
3
0
RT @lung_connect: 📣 HCPs 📣.Do you treat pts w/ rare alterations of #NSCLC?. Medical Oncologist Dr @JSabari and Debra Montague (President of….
0
1
0
Getting excited for ASCO 2025! Join us Sat, May 31 at The Sheraton Grand Chicago Riverwalk in Chicago 6 Ballroom for #PrecisionMedicine in #NSCLC at #ASCO25! 6:30 PM CDT Reg & Dinner | 7 PM CDTSymposium. @PeerView @LUNGevity @OncBrothers ➡️
0
18
26
Real World Data on Overall Survival in EGFR mutant NSCLC treated with first line Osimertinib @Perlmutter_CC @nyulangone @JTOonline .
2
18
64
Excited to work with CURE as the new editor in chief! Thank you @DrDebuTripathy for your vision. CURE magazine provides cutting edge advancements for patients with cancer, families and caregivers.@Perlmutter_CC @MDAndersonNews @cure_today
0
2
12
RT @jillfeldman4: Our goal is to help early career investigators foster collaborations early in their careers and support their important w….
0
16
0
RT @StephenVLiu: PALOMA-3 results @JCO_ASCO after #ASCO24 oral presentation. Subcutaneous vs intravenous amivantamab (with lazertinib) in p….
0
34
0
What an amazing experience discussing practice changing lung cancer abstracts #ASCO24 with @OncBrothers @Perlmutter_CC @NYUGSOM_HemeOnc @nyulangone.
Lung Ca Highlights from #ASCO24 w/ @JSabari . - #LAURA.- #MARIPOSA+#PALOMA3.- #CROWN.- #ADRIATIC . Full 🗣️ .- - - The “Oncology Brothers” podcast . #lcsm @ASCO #OncTwitter #MedTwitter @TargetedOnc @jillfeldman4 @EGFRResisters
0
2
15
RT @OncBrothers: Lung Ca Highlights from #ASCO24 w/ @JSabari . - #LAURA.- #MARIPOSA+#PALOMA3.- #CROWN.- #ADRIATIC . Full 🗣️ .- https://t.co….
0
22
0
Stay “cure-ious” @VamsiVelcheti. We NEED better perioperative approaches that will lead to more cures in our patients with early stage NSCLC. Two lung cancer Giants in the same shot. @OncLiveSOSS @Perlmutter_CC
1
2
11
Don’t miss it! Join us @OncLiveSOSS Lung Cancer @Perlmutter_CC @VamsiVelcheti @ElaineShumMD @salmanpunekar @sallylau @abrahamchachoua @nyulangone Thursday December 14th, 2023 6-9PM Martinique New York on Broadway, 49 W 32 St.
0
1
6
RT @EGFRSummit: ⏰ NEW DEADLINE ALERT ⏰. Hurry, it's your final shot! Submit your abstract for #EGFRSummit by 9/11. SUBMIT HERE: https://t.….
0
9
0
RT @CancerNetwrk: .@AlexSpiraMDPhD led a panel of experts to discuss current treatment options for patients with EGFR exon 20 non–small cel….
0
1
0
RT @rohit_thum: Our study of clinical/genomic predictors of response and toxicity to sotorasib in KRAS G12C+ NSCLC we recently presented at….
0
9
0
RT @Perlmutter_CC: Treating patients with KRAS-mutant lung cancer and untreated CNS metastasis with Adagrasib shows promising intracranial….
0
2
0